Cytokines and chemokines shaping the B-cell compartment

Cytokine and Growth Factor Reviews

Volumn 18, Issue 1-2, 2007, Pages 73-83

  Acosta Rodríguez, Eva V ^a   Merino, Maria C ^a   Montes, Carolina L ^a   Motrán, C Cristina ^a   Gruppi, Adriana ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

B cell; Humoral response; Lymphocyte compartmentalization; Lymphocyte development

Indexed keywords

CHEMOKINE; CYTOKINE;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW; CELL COMPARTMENTALIZATION; CELL HOMING; CELL MATURATION; HUMAN; IMMUNE RESPONSE; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTE SUBSETS; CELL DIFFERENTIATION; CHEMOKINES; CYTOKINES; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOLOGIC MEMORY; PLASMA CELLS;

MUS;

EID: 33947160089     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2007.01.007     Document Type: Article

References (109)

1. Chung J., Silverman M., and Monroe J. Transitional B cells: step by step towards immune competence. Trends Immunol 24 (2003) 343-349
2. Carsetti R. The development of B cells in the bone marrow is controlled by the balance between cell-autonomous mechanisms and signals from the microenvironment. J Exp Med 191 (2000) 5-8
3. Martin F., and Kearney J. B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol 13 (2001) 195-201
4. de Vinuesa C.G., Cook M.C., Ball J., Drew M., Sunners Y., Cascalho M., et al. Germinal centers without T cells. J Exp Med 191 (2000) 485-494
5. Rolink A.G., Winkler T., Melchers F., and Andersson J. Precursor B cell receptor-dependent B cell proliferation and differentiation does not require the bone marrow or fetal liver environment. J Exp Med 191 (2000) 23-32
6. Kee B.L., Cumano A., Iscove N.N., and Paige C.J. Stromal cell independent growth of bipotent B cell-macrophage precursors from murine fetal liver. Int Immunol 6 (1994) 401-407
7. Marshall A.J., Fleming H.E., Wu G.E., and Paige C.J. Modulation of the IL-7 dose-response threshold during pro-B cell differentiation is dependent on pre-B cell receptor expression. J Immunol 161 (1998) 6038-6045
8. Wiles M., Ruiz P., and Imhof B. Interleukin-7 expression during mouse thymus development. Eur J Immunol 22 (1992) 1037-1042
9. Funk P., Stephan R., and Witte P. Vascular cell adhesion molecule 1-positive reticular cells express interleukin-7 and stem cell factor in the bone marrow. Blood 86 (1995) 2661-2671
10. Lu L., Chaudhury P., and Osmond D.G. Regulation of cell survival during B lymphopoiesis: apoptosis and Bcl-2/Bax content of precursor B cells in bone marrow of mice with altered expression of IL-7 and recombinase-activating Gene-2. J Immunol 162 (1999) 1931-1940
11. Boise L., Minn A., June C., Lindsten T., and Thompson C. Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division. PNAS 92 (1995) 5491-5495
12. Muegge K., Vila M., and Durum S. Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor beta gene. Science 261 (1993) 93-95
13. von Freeden-Jeffry U., Vieira P., Lucian L., McNeil T., Burdach S., and Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 181 (1995) 1519-1526
14. Malek T., Porter B., and He Y. Multiple gamma c-dependent cytokines regulate T-cell development. Immunol Today 20 (1999) 71-76
15. Leonard W., and Spolski R. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol 5 (2005) 688-698
16. Levin S.D., Koelling R.M., Friend S.L., Isaksen D.E., Ziegler S.F., Perlmutter R.M., et al. Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM + B cells in vitro and signals via a novel mechanism. J Immunol 162 (1999) 677-683
17. Peschon J.J., Morrissey P.J., Grabstein K.H., Ramsdell F.J., Maraskovsky E., Gliniak B.C., et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 180 (1994) 1955-1960
18. DiSanto J., Muller W., Guy-Grand D., Fischer A., and Rajewsky K. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor {gamma} chain. PNAS 92 (1995) 377-381
19. Corcoran A., Riddell A., Krooshoop D., and Venkitaraman A. Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature 391 (1998) 904-907
20. Vosshenrich C., Cumano A., Muller W., Di Santo J., and Vieira P. Thymic stromal-derived lymphopoietin distinguishes fetal from adult B cell development. Nat Immunol 4 (2003) 773-779
21. -/- mice. J Exp Med 194 (2001) 1141-1150
22. Kondo M., Scherer D.C., Miyamoto T., King A.G., Akashi K., Sugamura K., et al. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature 407 (2000) 383-386
23. Dias S., Silva Jr. H., Cumano A., and Vieira P. Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors. J Exp Med 201 (2005) 971-979
24. Miller J.P., Izon D., DeMuth W., Gerstein R., Bhandoola A., and Allman D. The earliest step in B lineage differentiation from common lymphoid progenitors is critically dependent upon interleukin 7. J Exp Med 196 (2002) 705-711
25. Akashi K., Kondo M., and Weissman I. Role of interleukin-7 in T-cell development from hematopoietic stem cells. Immunol Rev 165 (1998) 13-28
26. Zou Y., Kottmann A., Kuroda M., Taniuchi I., and Littman D. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393 (1998) 595-599
27. Ma Q., Jones D., and Borghesani P.R. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. PNAS 95 (1998) 9448-9453
28. Honczarenko M., Douglas R.S., Mathias C., Lee B., Ratajczak M.Z., and Silberstein L.E. SDF-1 responsiveness does not correlate with CXCR4 expression levels of developing human bone marrow B cells. Blood 94 (1999) 2990-2998
29. Marsters S., Yan M., Pitti R., Haas P., Dixit V., and Ashkenazi A. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr Biol 10 (2000) 785-788
30. Mackay F., and Ambrose C. The TNF family members BAFF and APRIL: the growing complexity. Cytokine Growth Factor Rev 14 (2003) 311-324
31. Scapini P., Nardelli B., Nadali G., Calzetti F., Pizzolo G., Montecucco C., et al. G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J Exp Med 197 (2003) 297-302
32. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190 (1999) 1697-1710
33. Batten M., Groom J., Cachero T.G., Qian F., Schneider P., Tschopp J., et al. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 192 (2000) 1453-1466
34. Claudio E., Brown K., Park S., Wang H., and Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol 3 (2002) 958-965
35. Rothstein T.L. Cutting edge commentary: two B-1 or not to be one. J Immunol 168 (2002) 4257-4261
36. Hayakawa K., and Hardy R. Development and function of B-1 cells. Curr Opin Immunol 12 (2000) 346-353
37. Hitoshi Y., Yamaguchi N., Mita S., Sonoda E., Takaki S., Tominaga A., et al. Distribution of IL-5 receptor-positive B cells, expression of IL-5 receptor on Ly-1(CD5) + B cells. J Immunol 144 (1990) 4218-4225
38. Tominaga T., Takaki A., Koyama S., Katoh N., Matsumoto S., Migita R., et al. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J Exp Med 173 (1991) 429-437
39. Kopf M., Brombacher F., Hodgkin P.D., Ramsay A.J., Milbourne E.A., Dai W.J., et al. IL-5-deficient mice have a developmental defect in CD5 + B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4 (1996) 15-24
40. Yoshida T., Ikuta K., Sugaya H., Maki K., Takagi M., Kanazawa H., et al. Defective B-1 cell development and impaired immunity against angiostrongylus cantonensis in IL-5R alpha-deficient mice. Immunity 4 (1996) 483-494
41. Vink A., Warnier G., Brombacher F., and Renauld J.C. Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population. J Exp Med 189 (1999) 1413-1423
42. Fu Y., and Chaplin D. Development and maturation of secondary lymphoid tissues. Annu Rev Immunol 17 (1999) 399-433
43. Mariathasan S., Matsumoto M., Baranyay F., Nahm M., Kanagawa O., and Chaplin D. Absence of lymph nodes in lymphotoxin-alpha(LT alpha)-deficient mice is due to abnormal organ development, not defective lymphocyte migration. J Inflamm 45 (1995) 72-78
44. Kim D., Mebius R.E., MacMicking J.D., Jung S., Cupedo T., Castellanos Y., et al. Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE. J Exp Med 192 (2000) 1467-1478
45. Tumanov A., Kuprash D., and Nedospasov S. The role of lymphotoxin in development and maintenance of secondary lymphoid tissues. Cytokine Growth Factor Rev 14 (2003) 275-288
46. Muller G., Hopken U., and Lipp M. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol Rev 195 (2003) 117-135
47. Cyster J. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol 23 (2005) 127-159
48. Cyster J.G., Ansel K.M., Reif K., Ekland E.H., Hyman P.L., Tang H.L., et al. Follicular stromal cells and lymphocyte homing to follicles. Immunol Rev 176 (2000) 181-193
49. Okada T., Miller M.J., Parker I., Krummel M.F., Neighbors M., Hartley S.B., et al. Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. PLoS Biol 3 (2005) e150
50. Nie Y., Waite J., Brewer F., Sunshine M.J., Littman D.R., and Zou Y.R. The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity. J Exp Med 200 (2004) 1145-1156
51. Ishikawa S., Sato T., Abe M., Nagai S., Onai N., Yoneyama H., et al. Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b + CD11c + dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J Exp Med 193 (2001) 1393-1402
52. Ansel K., Harris R., and Cyster J. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 16 (2002) 67-76
53. Ansel K.M., Ngo V.N., Hyman P.L., Luther S.A., Forster R., Sedgwick J.D., et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406 (2000) 309-314
54. Lu T.T., and Cyster J.G. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 297 (2002) 409-412
55. Rosen H., Sanna G., and Alfonso C. Egress: a receptor-regulated step in lymphocyte trafficking. Immunol Rev 195 (2003) 160-177
56. Schwab S.R., Pereira J.P., Matloubian M., Xu Y., Huang Y., and Cyster J.G. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309 (2005) 1735-1739
57. Snapper C., Paul W., and Interferon-gamma. B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236 (1987) 944-947
58. Pene J., Gauchat J.F., Lecart S., Drouet E., Guglielmi P., Boulay V., et al. Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J Immunol 172 (2004) 5154-5157
59. Malisan F., Briere F., Bridon J.M., Harindranath N., Mills F.C., Max E.E., et al. Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes. J Exp Med 183 (1996) 937-947
60. Cazac B., and Roes J. TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 13 (2000) 443-451
61. Paus D., Phan T.G., Chan T.D., Gardam S., Basten A., and Brink R. Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J Exp Med 203 (2006) 1081-1091
62. McHeyzer-Williams M., McLean M., Lalor P., and Nossal G. Antigen-driven B cell differentiation in vivo. J Exp Med 178 (1993) 295-307
63. McHeyzer-Williams L., Driver D., and McHeyzer-Williams M. Germinal center reaction. Curr Opin Hematol 8 (2001) 52-59
64. Cozine C., Wolniak K., and Waldschmidt T. The primary germinal center response in mice. Curr Opin Immunol 17 (2005) 298-302
65. Acosta-Rodriguez E.V., Zuniga E., Montes C.L., and Gruppi A. Interleukin-4 biases differentiation of B cells from Trypanosoma cruzi-infected mice and restrains their fratricide: role of Fas ligand down-regulation and MHC class II-transactivator up-regulation. J Leukoc Biol 73 (2003) 127-136
66. Arpin C., Dechanet J., Van Kooten C., Merville P., Grouard G., Briere F., et al. Generation of memory B cells and plasma cells in vitro. Science 268 (1995) 720-722
67. Agematsu K., Nagumo H., Oguchi Y., Nakazawa T., Fukushima K., Yasui K., et al. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood 91 (1998) 173-180
68. Kawano M.M., Liu S., Otsuyama K., and Asaoku H. Transdifferentiation of human myeloma cells and their dedifferentiation by IL-6. Blood 106 (2005) 3408 (ASH Annual Meeting Abstracts)
69. Jego G., Palucka A., Blanck J., Chalouni C., Pascual V., and Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19 (2003) 225-234
70. Ozaki K., Spolski R., Ettinger R., et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol 173 (2004) 5361-5371
71. Avery D.T., Kalled S.L., Ellyard J.I., et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J Clin Invest 112 (2003) 286-297
72. MacLennan I., and Vinuesa C. Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses. Immunity 17 (2002) 235-238
73. Shapiro-Shelef M., and Calame K. Regulation of plasma-cell development. Nat Rev Immunol 5 (2005) 230-242
74. Dent A., Vasanwala F., and Toney L. Regulation of gene expression by the proto-oncogene BCL-6. Crit Rev Oncol Hematol 41 (2002) 1-9
75. Reljic R., Wagner S.D., Peakman L.J., and Fearon D.T. Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6. J Exp Med 192 (2000) 1841-1848
76. Acosta-Rodriguez E.V., Montes C.L., Motran C.C., Zuniga E.I., Liu F.T., Rabinovich G.A., et al. Galectin-3 mediates IL-4-induced survival and differentiation of B cells: functional cross-talk and implications during Trypanosoma cruzi infection. J Immunol 172 (2004) 493-502
77. Traggiai E., Puzone R., and Lanzavecchia A. Antigen dependent and independent mechanisms that sustain serum antibody levels. Vaccine 21 Suppl 2 (2003) S35-S37
78. Lesinski G., and Westerink M. Novel vaccine strategies to T-independent antigens. J Microbiol Methods 47 (2001) 135-149
79. Minoprio P. Parasite polyclonal activators: new targets for vaccination approaches?. Int J Parasitol 31 (2001) 588-591
80. Montes C., Vottero-Cima E., and Gruppi A. Trypanosoma cruzi cytosolic alkaline antigens (FI) induce polyclonal activation in murine normal B cells. Scand J Immunol 44 (1996) 93-100
81. Montes C., Zuniga E., Minoprio P., Vottero-Cima E., and Gruppi A. A Trypanosoma cruzi alkaline antigen induces polyclonal B-cell activation of normal murine spleen cells by T-cell-independent, BCR-directed stimulation. Scand J Immunol 50 (1999) 159-166
82. Silva E., Ramos O., Bauab T., Falcao D., and de Medeiros B. Yersinia enterocolitica O:3 isolated from patients with or without reactive arthritis induces polyclonal activation of B cells and autoantibody production in vivo. Autoimmunity 36 (2003) 261-268
83. Hunziker L., Recher M., Macpherson A., Ciurea A., Freigang S., Hengartner H., et al. Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections. Nat Immunol 4 (2003) 343-349
84. Ochsenbein A.F., Fehr T., Lutz C., Suter M., Brombacher F., Hengartner H., et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286 (1999) 2156-2159
85. Riva S., Nolli M., Lutz M., Citterio S., Girolomoni G., Winzler C., et al. Bacteria and bacterial cell wall constituents induce the production of regulatory cytokines in dendritic cell clones. J Inflamm 46 (1996) 98-105
86. Markine-Goriaynoff D., Nguyen T.D., Bigaignon G., Van Snick J., and Coutelier J.-P. Distinct requirements for IL-6 in polyclonal and specific Ig production induced by microorganisms. Int Immunol 13 (2001) 1185-1192
87. Karupiah G., Sacks T., Klinman D., Fredrickson T.N., Hartley J.W., Chen J.H., et al. Murine cytomegalovirus infection-induced polyclonal B cell activation is independent of CD4 + T cells and CD40. Virology 240 (1998) 12-26
88. Nakajima K., Martinez-Maza O., Hirano T., Breen E.C., Nishanian P.G., Salazar-Gonzalez J.F., et al. Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. J Immunol 142 (1989) 531-536
89. He B., Qiao X., and Cerutti A. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J Immunol 173 (2004) 4479-4491
90. Kacani L., Sprinzl G., Erdei A., and Dierich M. Interleukin-15 enhances HIV-1-driven polyclonal B-cell response in vitro. Exp Clin Immunogenet 16 (1999) 162-172
91. Litinskiy M., Nardelli B., Hilbert D., He B., Schaffer A., Casali P., et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 3 (2002) 822-829
92. Schneider P. The role of APRIL and BAFF in lymphocyte activation. Curr Opin Immunol 17 (2005) 282-289
93. Montes C., Acosta-Rodriguez E., Mucci J., Zuniga E., Campetella O., and Gruppi A. A Trypanosoma cruzi antigen signals CD11b + cells to secrete cytokines that promote polyclonal B cell proliferation and differentiation into antibody-secreting cells. Eur J Immunol 36 (2006) 1474-1485
94. He B., Qiao X., Klasse P.J., Chiu A., Chadburn A., Knowles D.M., et al. HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors. J Immunol 176 (2006) 3931-3941
95. Sangster M.Y., Topham D.J., D'Costa S., Cardin R.D., Marion T.N., Myers L.K., et al. Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus. J Immunol 164 (2000) 1820-1828
96. Ho M., Tongtawe P., Kriangkum J., Wimonwattrawatee T., Pattanapanyasat K., Bryant L., et al. Polyclonal expansion of peripheral gamma delta T cells in human Plasmodium falciparum malaria. Infect Immun 62 (1994) 855-862
97. De Paoli P., Basaglia G., Gennari D., Crovatto M., Modolo M.L., and Santini G. Phenotypic profile and functional characteristics of human gamma and delta T cells during acute toxoplasmosis. J Clin Microbiol 30 (1992) 729-731
98. Pillai S., Cariappa A., and Moran S. Marginal zone B cells. Annu Rev Immunol 23 (2005) 161-196
99. Martin F., Oliver A., and Kearney J. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14 (2001) 617-629
100. Tumang J.R., Frances R., Yeo S.G., and Rothstein T.L. Cutting edge: spontaneously Ig-secreting B-1 Cells violate the accepted paradigm for expression of differentiation-associated transcription factors. J Immunol 174 (2005) 3173-3177
101. Watanabe N., Ikuta K., Nisitani S., Chiba T., and Honjo T. Activation and differentiation of autoreactive B-1 cells by interleukin 10 induce autoimmune hemolytic anemia in fas-deficient antierythrocyte immunoglobulin transgenic mice. J Exp Med 196 (2002) 141-146
102. Watanabe N., Ikuta K., Fagarasan S., Yazumi S., Chiba T., and Honjo T. Migration and differentiation of autoreactive B-1 cells induced by activated {gamma}/{delta} T cells in antierythrocyte immunoglobulin transgenic mice. J Exp Med 192 (2000) 1577-1586
103. Taki S., Schmitt M., Tarlinton D., Forster I., and Rajewsky K. T cell-dependent antibody production by Ly-1 B cells. Ann N Y Acad Sci 651 (1992) 328-335
104. Ebeling S., Schutte M., and Logtenberg T. The majority of human tonsillar CD5 + B cells express somatically mutated V kappa 4 genes. Eur J Immunol 23 (1993) 1405-1408
105. Moon B., Takaki S., Miyake K., and Takatsu K. The role of IL-5 for mature B-1 cells in homeostatic proliferation, cell survival, and Ig production. J Immunol 172 (2004) 6020-6029
106. Berland R., and Wortis H. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 20 (2002) 253-300
107. Ishida H., Hastings R., Kearney J., and Howard M. Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J Exp Med 175 (1992) 1213-1220
108. Kuhn R., Lohler J., Rennick D., Rajewsky K., and Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993) 263-274
109. Nisitani S., Tsubata T., Murakami M., and Honjo T. Administration of interleukin-5 or -10 activates peritoneal B-1 cells and induces autoimmune hemolytic anemia in anti-erythrocyte autoantibody-transgenic mice. Eur J Immunol 25 (1995) 3047-3052